Advances in modification and delivery of nucleic acid drugs. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue Ban, 2023 Wang J, Tan M, Wang Y, Liu X, Lin A.
europepmc +1 more source
[Epidemiological characteristics of infectious diseases of group A, B and C among Chinese students' population]. [PDF]
Beijing Da Xue Xue Bao Yi Xue Ban, 2021 Dong YH +8 more
europepmc +1 more source
[Clinical characteristics of influenza pneumonia in the elderly and relationship between D-dimer and disease severity]. [PDF]
Beijing Da Xue Xue Bao Yi Xue Ban, 2022 Li J, Xu Y, Wang YY, Gao ZC.
europepmc +1 more source
[Bioactive compounds of Jingfang Granules against SARS-CoV-2 virus proteases 3CLpro and PLpro]. [PDF]
Beijing Da Xue Xue Bao Yi Xue Ban, 2022 Shang ZP +6 more
europepmc +1 more source
[Reflections on the Global Pandemic of COVID-19 and the Response Strategies]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue Ban, 2021 Lu Q.
europepmc +1 more source
[Reflections on the Application of Critical Care Ultrasound in Viral Pneumonia Patients with Circulatory Dysfunction-New Classification and Precision Treatment Based on Ciritical Care Ultrasound]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue Ban, 2021 Qin Y +5 more
europepmc +1 more source
Risk factors for venoarterial-extracorporeal membrane oxygenation related nosocomial infection in children after cardiac surgery. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2022 Wang C +7 more
europepmc +1 more source
, 2018 癌症和传染性疾病等仍为人类健康生活的严重威胁，而相关的生物标志物的快速、准确检测是有效应对的前提。蛋白和核酸标志物是当前体外诊断的主要目标分子，而针对蛋白检测的免疫技术一般敏感性较差，故核酸分子靶标为对象的检测技术成为主流。核酸检测中成熟的PCR及其衍生技术因严格的温控和精密仪器等需求而限制了应用场景。而以环介导恒温扩增（LAMP）为代表的新技术具有简便、快速、高特异性和高灵敏性的优势。然而，LAMP等恒温扩增技术引物设计复杂并受到严格专利保护，制约了真正的应用。同时 ...
毛瑞
core
[Clinical features of children with influenza and plastic bronchitis: an analysis of 63 cases]. [PDF]
Zhongguo Dang Dai Er Ke Za Zhi, 2020 Wei F, Wen FQ, Yang WG, Zheng YJ.
europepmc +1 more source
[The mechanism and treatment strategies of SARS-CoV-2 mediated inflammatory response]. [PDF]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2020 Han N, Du L, Yan L, Tang H.
europepmc +1 more source